May 20, 2015 Linda Porter, Ph.D. The National Institute of Neurological Disorders and Stroke (NINDS) Office of Pain Policy/National Institutes of Health (NIH) 31 Center Drive, Room 8A31 Bethesda, MD 20892 Re: National Pain Strategy Public Comments Dr. Porter, The purpose of this letter is to provide comments on the draft National Pain Strategy, as […]
November 5, 2015 Janet Woodcock, MD Director Center for Drug Evaluation and Research U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: Follow-up to Meeting to Protect Access to Pain Relief Dear Dr. Janet Woodcock: We want to thank the Food and Drug Administration (FDA) for the time that Dr. […]
Washington, DC (July 22, 2015) – Today, the Protecting Access to Pain Relief (PAPR) Coalition officially launched to help ensure that American consumers continue to have access to, and choice of, safe and effective pain relief that is best suited to manage their condition. Founded by advocates for pain relief, the PAPR Coalition includes multiple […]
Acetaminophen is one of the most commonly used analgesic compounds worldwide and an ingredient in hundreds of over-the-counter (OTC) and prescription (Rx) products.1 These include single-ingredient OTC pain products; combination OTC products for additional relief of symptoms of cold, flu, sinus, and allergy, and for sleeplessness; and Rx combinations with narcotic analgesics. While acetaminophen has […]
Acetaminophen is a widely used medication present in hundreds of over-the-counter (OTC) and prescription (Rx) medications indicated for pain or fever as well as symptoms associated with colds, flu, and allergies. It is considered safe when dosed as directed but, in high doses, has been associated with liver injury, and overuse is reported to be […]
The Food and Drug Administration on Thursday strengthened safety warnings on widely used over-the-counter and prescription painkillers, such as ibuprofen and naproxen, letting consumers know that these medications can increase people’s chances of a heart attack or stroke. Here are some answers to frequently asked questions about the change: Which drugs will get the new […]
SILVER SPRING, Md., July 10 (UPI) — The Food and Drug Administration is strengthening warnings on prescription and over-the-counter nonsteroidal anti-inflammatory drugs, or NSAIDs, to include stronger and more specific warnings about the drugs increasing risk of heart attack and stroke. The warning applies to drugs such as Advil, Aleve, Celebrex and other versions of […]
Around 100 million Americans live with persistent pain–more than are affected by diabetes, cancer, and heart disease combined. This latest volume of The Silver Book brings together all of the data on persistent pain, all into one place. Visit www.silverbook.org for more information. The full PDF is available here There are variant cases such as bipolar frustration […]
David W Kaufman1*, Judith P Kelly1, Jeffrey M Rohay2, Mary Kathryn Malone3, Rachel B Weinstein4 and Saul Shiffman2,5 1 Slone Epidemiology Center at Boston University, Boston, MA, USA, 2 Pinney Associates, Pittsburgh, PA, USA, 3 Appleseed Consumer Insight, Arlington, MA, USA, 4 Janssen Research and Development, Titusville, NJ, USA, 5 University of Pittsburgh, Pittsburgh, PA, […]
Kenneth J. Rothman* and Lee L. LanzaRTI Health Solutions, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709-2194, USAAbstract Objective: We assessed the net effect on risk of death for within-label use of acetaminophen and the two non- aspirin alternative oral non-prescription analgesics available in the U.S. (ibuprofen and naproxen sodium) in relation […]
PAPR Coalition members meet with Administration leadership at the White House on May 8, 2018.
